Stock Crash: Outperforming contract research firm tanks 14% after Q4 results

Ahead of Friday’s fall, Sai Life Sciences’ shares had surged more than 100% from its IPO price of ₹549, and was also near its 52-week high of ₹1,139.

Leave a Reply

Your email address will not be published. Required fields are marked *